NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/19/2022
Back to search
Official data from USPTO
EPIZYMENOW
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPIZYMENOW
ST13
US500000090144500Class
36, 44
Filing
90144500
Registration
6791935
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
07/19/2022
Trademark type
Word
Nice classes
36, 44
Filing date
08/28/2020
Registration date
07/19/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/19/2022
Last transaction
07/19/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2020-03-00
First use in commerce
2020-03-00
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
CROSS, TRACY L
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Epizyme, Inc.
Representatives
Douglas R. Wolf WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Providing financial support services for patients and caregiversproviding financial assistance and related financial information to patients and caregivers
Class 44
Providing support services for patients and caregiversproviding information about medication and diagnostics
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2022
PUBO
PUBLISHED FOR OPPOSITION
05/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/28/2022
ALIE
ASSIGNED TO LIE
03/28/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/28/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/28/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/28/2022
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
03/14/2022
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
03/14/2022
CNCF
ACTION CONTINUING A FINAL - COMPLETED
03/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/04/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/08/2021
GNFR
FINAL REFUSAL E-MAILED
08/08/2021
CNFR
FINAL REFUSAL WRITTEN
08/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2021
GNRT
NON-FINAL ACTION E-MAILED
01/07/2021
CNRT
NON-FINAL ACTION WRITTEN
01/07/2021
DOCK
ASSIGNED TO EXAMINER
12/30/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens EPIZYMENOW or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.